Adapting and Piloting Behavioral Activation for Veterans With Alcohol Use Disorder and Posttraumatic Stress Disorder
Launched by RTI INTERNATIONAL · Feb 7, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to help U.S. military veterans who are dealing with both alcohol use disorder (AUD) and posttraumatic stress disorder (PTSD). The study aims to compare two types of therapy: an adapted version of Behavioral Activation, which focuses on encouraging positive activities, and Relapse Prevention, which helps individuals avoid returning to harmful behaviors. Researchers want to see how well these treatments work for veterans and whether they can measure recovery using new geospatial analysis techniques.
To be eligible for this trial, participants need to be veterans aged 18 to 65 who meet specific criteria for both AUD and PTSD. They should have experienced heavy drinking in the past month and have difficulties in their daily functioning. Participants will take part in eight therapy sessions, delivered individually by trained therapists, and will complete surveys before and after the treatment to share their experiences. This trial is currently recruiting, and all genders are welcome to participate. It’s a chance to try new therapeutic approaches while contributing to important research aimed at improving mental health care for veterans.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Be a U.S. veteran,
- • 2. Be at least 18 years old,
- • 3. Meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for current AUD,
- • 4. Report 3+ heavy drinking days (5+ drinks for men/4+ drinks for women) or 1+ heavy drinking week (15+ drinks men/8+ drinks women) in the past 30 days,
- • 5. Meet DSM-5 criteria for current PTSD or satisfy the definition of current subthreshold PTSD (i.e., up to one of symptom clusters B-E may fall below diagnostic threshold),
- • 6. Be fluent and literate in English, and
- • 7. Be able to provide voluntary, informed consent to participate.
- Exclusion Criteria:
- • 1. Current mania/hypomania or current psychosis,
- • 2. Lifetime alcohol withdrawal-related seizures, delirium, or hallucinations,
- • 3. Prior inpatient alcohol withdrawal management,
- • 4. Current DSM-5 severe drug use disorder (DUD) except for severe tobacco use disorder,
- • 5. Psychotropic (including alcohol abstinence) medication changes within 30 days of study enrollment or plans to change medications during the study,
- • 6. Current/planned non-study BA for any disorder during the study, or
- • 7. Current/planned evidence-based psychotherapy for AUD, PTSD, or DUD during the study.
About Rti International
RTI International is a leading nonprofit research institute dedicated to improving the human condition through innovative scientific research and technical assistance. With a strong focus on health and social science, RTI collaborates with various stakeholders, including government agencies, private organizations, and academic institutions, to advance knowledge and drive impactful solutions. The organization is recognized for its rigorous methodologies and commitment to ethical research practices, making it a trusted sponsor for clinical trials aimed at enhancing public health and advancing medical science. Through its comprehensive approach, RTI International contributes to the development of evidence-based strategies that address pressing health challenges globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Shannon M Blakey, PhD
Principal Investigator
RTI International
Eric B Elbogen, PhD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported